EyeGene Revenue

In the year 2025, EyeGene had annual revenue of 3.57B KRW with 6.29% growth. EyeGene had revenue of 774.00M in the quarter ending December 31, 2025, a decrease of -40.97%.

Revenue

3.57B

Revenue Growth

+6.29%

P/S Ratio

17.56

Revenue / Employee

n/a

Employees

n/a

Market Cap

62.64B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.57B	211.02M	6.29%
Dec 31, 2024	3.36B	230.37M	7.37%
Dec 31, 2023	3.13B	-2.17B	-40.96%
Dec 31, 2022	5.29B	2.05B	63.27%
Dec 31, 2021	3.24B	-121.31M	-3.61%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Aptamer Sciences	1.08B
HLB Pep	4.96B
Ark Solutions	16.08B
Psomagen	59.19B
ADBiotech	12.90B
J2KBIO	32.97B
IMGT Co.,Ltd.	102.33M
Progen	450.00M

Revenue Rankings